X4 Pharmaceuticals, Inc. (XFOR)
3.91
+0.03
(+0.77%)
USD |
NASDAQ |
Dec 12, 16:00
3.92
+0.01
(+0.26%)
After-Hours: 20:00
X4 Pharmaceuticals Free Cash Flow: -106.13M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 10.38B |
| Altimmune, Inc. | -66.66M |
| Adverum Biotechnologies, Inc. | -138.44M |
| Hims & Hers Health, Inc. | 116.09M |
| Recursion Pharmaceuticals, Inc. | -450.20M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.82M |
| Cash from Investing (Quarterly) | -28.67M |
| Cash from Financing (Quarterly) | 86.90M |
| Free Cash Flow Per Share (Quarterly) | -0.6429 |
| Free Cash Flow to Equity (Quarterly) | -27.16M |
| Free Cash Flow to Firm (Quarterly) | -25.57M |
| Free Cash Flow Yield | -168.8% |